360 Block Gel
COMMON PRODUCTS - gel - 50 g
Standard delivery
₹899
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated August 2026
Medicines with the same active ingredient and strength as Entavir 0.5MG Tab.
You are viewing
Entavir 0.5MG Tab
tablet - 0.5 mg - 10 S
₹913
₹91.30 per tablet
ZYDUS HEALTHCARE PHARMA · tablet - 0.5 mg - 30 S · Rx
₹2,706
₹90.19 per tablet
Entecavir (0.5mg)
Treatment of chronic hepatitis B virus (HBV) infection in adults (and eligible adolescents/children as prescribed), including patients with compensated liver disease; may also be used in lamivudine-resistant HBV as per specialist advice.
Entecavir is a nucleoside analogue antiviral that inhibits hepatitis B virus DNA polymerase (reverse transcriptase). It blocks viral DNA replication, reducing HBV viral load and liver inflammation over time.
Oral tablet. Take exactly as prescribed, usually once daily. Take on an empty stomach (at least 2 hours after food and at least 2 hours before the next meal). Do not stop abruptly without medical advice.
Common side effects of Entavir 0.5MG Tab may include:
COMMON PRODUCTS - gel - 50 g
Standard delivery
COMMON PRODUCTS - cream - 20 g
Standard delivery
COMMON PRODUCTS - gel - 50 g
Standard delivery
COMMON PRODUCTS - gel - 50 ml
Standard delivery
COMMON PRODUCTS - 70 g
Standard delivery
COMMON PRODUCTS - 150 ml
Standard delivery
COMMON PRODUCTS - gel - 20 g
Standard delivery
COMMON PRODUCTS - 30 ml
Standard delivery
A substitute contains the same active ingredient (salt), in the same strength, as Entavir 0.5MG Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Not a cure for HBV; long-term therapy may be required. Stopping entecavir can cause severe acute exacerbation of hepatitis—liver function should be monitored for several months after discontinuation. Risk of lactic acidosis and severe hepatomegaly with steatosis (rare) especially in advanced liver disease; seek care for unusual weakness, muscle pain, breathing trouble, abdominal pain, or sudden worsening. Use cautiously in renal impairment; dose adjustment may be needed. HIV/HBV co-infection: do not use without effective antiretroviral therapy due to risk of HIV resistance. Not recommended for self-medication.